{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:16:02Z","timestamp":1781946962813,"version":"3.54.5"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.biopha.2020.111105","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T21:22:24Z","timestamp":1608153744000},"page":"111105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats"],"prefix":"10.1016","volume":"134","author":[{"given":"Val\u00e9ria","family":"T\u00e9kus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m Istv\u00e1n","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kata","family":"Csek\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Szabadfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kov\u00e1cs-Valasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bese","family":"D\u00e1ny\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Deres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Halmosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"S\u00e1ghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n V.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Adeghate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"K\u0151szegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"M\u00e1tyus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"G\u00e1briel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pint\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Helyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.111105_bib0005","series-title":"IDF Diabetes Atlas","year":"2019"},{"key":"10.1016\/j.biopha.2020.111105_bib0010","series-title":"IDF Diabetes Atlas","year":"2019"},{"key":"10.1016\/j.biopha.2020.111105_bib0015","series-title":"Global Report on Diabetes","year":"2016"},{"key":"10.1016\/j.biopha.2020.111105_bib0020","first-page":"71","article-title":"Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats","volume":"69","author":"Hayes","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111105_bib0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/cs0880675","article-title":"Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin","volume":"88","author":"Boomsma","year":"1995","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.biopha.2020.111105_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s001250051143","article-title":"Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis","volume":"42","author":"Boomsma","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.111105_bib0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neuint.2005.12.009","article-title":"Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats","volume":"48","author":"Somfai","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2020.111105_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12902-019-0392-1","article-title":"Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats","volume":"19","author":"Li","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.biopha.2020.111105_bib0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1464-5491.1999.00103.x","article-title":"Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy","volume":"16","author":"Garpenstrand","year":"1999","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2020.111105_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03190036","article-title":"Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis","volume":"24","author":"Meszaros","year":"1999","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2020.111105_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1056-8727(01)00151-9","article-title":"Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus","volume":"15","author":"Gronvall-Nordquist","year":"2001","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.biopha.2020.111105_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(02)00189-4","article-title":"Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis","volume":"323","author":"Karadi","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2020.111105_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2009.01.027","article-title":"Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects","volume":"403","author":"Li","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2020.111105_bib0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/ATVBAHA.111.238030","article-title":"Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations","volume":"32","author":"Aalto","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2020.111105_bib0075","article-title":"Serum vascular adhesion Protein-1 predicts end-stage renal disease in patients with type 2 diabetes","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.111105_bib0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/002215540104900208","article-title":"Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase","volume":"49","author":"Andres","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biopha.2020.111105_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-004-1346-2","article-title":"Adipocytes release a soluble form of VAP-1\/SSAO by a metalloprotease-dependent process and in a regulated manner","volume":"47","author":"Abella","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.111105_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1570-9639(03)00101-8","article-title":"Physiological and pathological implications of semicarbazide-sensitive amine oxidase","volume":"1647","author":"Yu","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.111105_bib0095","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/02713683.2017.1359847","article-title":"Soluble vascular adhesion Protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy","volume":"42","author":"Murata","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/diab.42.4.594","article-title":"Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes","volume":"42","author":"Yu","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.111105_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-7091-6499-0_19","article-title":"Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes","volume":"52","author":"Yu","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.biopha.2020.111105_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0021-9150(98)00142-7","article-title":"Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover","volume":"140","author":"Yu","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2020.111105_bib0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-291X(02)02293-3","article-title":"Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes","volume":"297","author":"Mathys","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2020.111105_bib0120","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/jpet.104.068601","article-title":"Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine","volume":"310","author":"Gubisne-Haberle","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.111105_bib0125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.exer.2009.07.010","article-title":"Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes","volume":"89","author":"Noda","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10408363.2015.1050714","article-title":"Vascular adhesion protein-1: role in human pathology and application as a biomarker","volume":"52","author":"Pannecoeck","year":"2015","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2020.111105_bib0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s001250050816","article-title":"Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications","volume":"40","author":"Yu","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.111105_bib0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/phrs.1997.0272","article-title":"Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus","volume":"37","author":"Ekblom","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep39863","article-title":"Analgesic and anti-inflammatory effects of the novel semicarbazide-sensitive amine-oxidase inhibitor SzV-1287 in chronic arthritis models of the mouse","volume":"7","author":"Horvath","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.111105_bib0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.phrs.2018.02.006","article-title":"Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors","volume":"131","author":"Horvath","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/ars.2017.7418","article-title":"Vascular adhesion Protein-1: a cell surface amine oxidase in translation","volume":"30","author":"Salmi","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2020.111105_bib0165","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/S0168-8278(15)30176-8","article-title":"Phase 1 results from PXS-4728A, a selective SSAO\/VAP-1 inhibitor, for the treatment of non-alcoholic steatohepatitis","volume":"62","author":"Jarolimek","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.111105_bib0170","unstructured":"A trial of BTT1023 in patients with primary sclerosing cholangitis, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02239211 (accessed May 29, 2016)."},{"key":"10.1016\/j.biopha.2020.111105_bib0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2019.02.034","article-title":"Emerging therapeutic agents in osteoarthritis","volume":"165","author":"Alcaraz","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111105_bib0180","series-title":"Semicarbazide-sensitive Amine-oxidase Inhibitors, As Analgesics in Traumatic Neuropathy and Neurogenic Inflammation, WO\/2015\/159112","author":"Helyes","year":"2015"},{"key":"10.1016\/j.biopha.2020.111105_bib0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/cmdc.201500406","article-title":"Metabolism-activated multitargeting (MAMUT): an innovative multitargeting approach to drug design and development","volume":"11","author":"Matyus","year":"2016","journal-title":"ChemMedChem."},{"key":"10.1016\/j.biopha.2020.111105_bib0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2016.02.049","article-title":"Helyes, Szoke, A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist","volume":"324","author":"Payrits","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2020.111105_bib0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00702-012-0961-1","article-title":"Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation","volume":"120","author":"T\u00e1bi","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2020.111105_bib0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.105.089649","article-title":"Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase","volume":"315","author":"Salter-Cid","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.111105_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/jpet.105.096958","article-title":"Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia","volume":"317","author":"Xu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.111105_bib0210","series-title":"Design, Synthesis, and Biological Evaluation of Semicarbazide-sensitive Amine Oxidase (SSAO) Inhibitors With Anti-inflammatory Activity","first-page":"2166","author":"Wang","year":"2006"},{"key":"10.1016\/j.biopha.2020.111105_bib0215","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00702-007-0699-3","article-title":"Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis","volume":"114","author":"O\u2019Rourke","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2020.111105_bib0220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.lfs.2010.12.003","article-title":"Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model","volume":"88","author":"Yang","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2020.111105_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2015.11.003","article-title":"Modeling long-term diabetes and related complications in rats","volume":"78","author":"Hajna","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.biopha.2020.111105_bib0230","series-title":"Inhibitors of Semicarbazide-sensitive Amine Oxidase (SSAO) and VAP-1 Mediated Adhesion Useful for Treatment of Diseases, WO\/2005\/014530","author":"Salter-Cid","year":"2005"},{"key":"10.1016\/j.biopha.2020.111105_bib0235","series-title":"Semicarbazide-sensitive Amine Oxidase Inhibitors, WO\/2006\/094201","author":"Salter-Cid","year":"2006"},{"key":"10.1016\/j.biopha.2020.111105_bib0240","series-title":"Compounds for Inhibiting Semicarbazide-sensitive Amine Oxidase (SSAO)\/vascular Adhesion protein-1 (VAP-1) and Uses Thereof for Treatment and Prevention of Diseases, WO\/2010\/029379","author":"M\u00e1tyus","year":"2010"},{"key":"10.1016\/j.biopha.2020.111105_bib0245","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1253395","article-title":"Streptozotocin causes pancreatic beta cell failure via early and sustained biochemical and cellular alterations","volume":"118","author":"Adeghate","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.biopha.2020.111105_bib0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12031-014-0296-5","article-title":"PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements","volume":"54","author":"Danyadi","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2020.111105_bib0255","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cvr\/cvp144","article-title":"PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats","volume":"83","author":"Bartha","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0260","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.29915","article-title":"Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice","volume":"68","author":"Varga","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.111105_bib0265","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fphys.2017.00935","article-title":"Alternative splicing of NOX4 in the failing human heart","volume":"8","author":"Varga","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2020.111105_bib0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clinbiochem.2016.10.018","article-title":"Antagonistic sepsis markers: serum gelsolin and actin\/gelsolin ratio","volume":"50","author":"Horv\u00e1th-Szalai","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2020.111105_bib0275","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0304-3959(99)00024-X","article-title":"Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat","volume":"81","author":"Fox","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2020.111105_bib0285","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1196\/annals.1372.032","article-title":"Vitamin E decreases the hyperglucagonemia of diabetic rats","volume":"1084","author":"Al-Shamsi","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2020.111105_bib0290","series-title":"Wall Melzack\u2019S Textb. Pain","first-page":"3","article-title":"Peripheral mechanisms of cutaneous nociception","author":"Meyer","year":"2006"},{"key":"10.1016\/j.biopha.2020.111105_bib0295","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918789812","article-title":"TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy","volume":"14","author":"Hiyama","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.biopha.2020.111105_bib0300","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/j.pain.0000000000001781","article-title":"Recovery from nerve injury induced behavioral hypersensitivity in rats parallels resolution of abnormal primary sensory afferent signaling","volume":"161","author":"Boada","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2020.111105_bib0305","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.nurt.2009.07.004","article-title":"Diabetic painful and insensate neuropathy: pathogenesis and potential treatments","volume":"6","author":"Obrosova","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2020.111105_bib0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.metabol.2015.12.002","article-title":"Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels","volume":"65","author":"Huang","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2020.111105_bib0315","first-page":"47","article-title":"Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy","volume":"19","author":"Valverde","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2020.111105_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.biopha.2020.111105_bib0325","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00049.2016","article-title":"Diastolic dysfunction in prediabetic male rats: role of mitochondrial oxidative stress","volume":"311","author":"Koncsos","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2020.111105_bib0330","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","article-title":"Interplay of oxidative, nitrosative\/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy","volume":"1852","author":"Varga","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.111105_bib0335","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/chromsci\/37.9.317","article-title":"Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications","volume":"37","author":"Deng","year":"1999","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.biopha.2020.111105_bib0340","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00125-002-0903-9","article-title":"Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet","volume":"45","author":"Yu","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.111105_bib0345","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.bjp.0706684","article-title":"Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats","volume":"147","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111105_bib0350","doi-asserted-by":"crossref","first-page":"E634","DOI":"10.1152\/ajpendo.00272.2003","article-title":"Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2020.111105_bib0355","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9440(10)62300-0","article-title":"Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse","volume":"166","author":"Merinen","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2020.111105_bib0360","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diabetes.50.9.2061","article-title":"Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats","volume":"50","author":"Marti","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.111105_bib0365","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/diabetes.52.4.1004","article-title":"Semicarbazide-sensitive amine oxidase\/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats","volume":"52","author":"Abella","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.111105_bib0370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041100318","article-title":"Comparison of the effects of insulin and H2O2 on adipocyte glucose transport","volume":"110","author":"Ciaraldi","year":"1982","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2020.111105_bib0375","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1073\/pnas.84.22.8115","article-title":"Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide","volume":"84","author":"Hayes","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2020.111105_bib0380","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0022-3565(24)37382-3","article-title":"Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide","volume":"285","author":"Marti","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2020.111105_bib0385","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3500171","article-title":"Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells","volume":"350","author":"Enrique-Tarancon","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2020.111105_bib0390","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3565(24)29571-9","article-title":"Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes","volume":"297","author":"Morin","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.111105_bib0395","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2353\/ajpath.2009.080612","article-title":"Semicarbazide-sensitive amine oxidase\/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition","volume":"174","author":"Bour","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2020.111105_bib0400","first-page":"702","article-title":"Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications","volume":"18","author":"Stolen","year":"2004","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.biopha.2020.111105_bib0405","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061293","article-title":"Human copper-containing amine oxidases in drug design and development","volume":"25","author":"Vakal","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2020.111105_bib0410","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI25437","article-title":"TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury","volume":"115","author":"Obata","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.111105_bib0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2006.01.031","article-title":"Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats","volume":"200","author":"Katsura","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2020.111105_bib0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuron.2006.03.042","article-title":"TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction","volume":"50","author":"Kwan","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2020.111105_bib0425","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1073\/pnas.0808487106","article-title":"TRPA1 acts as a cold sensor in vitro and in vivo","volume":"106","author":"Karashima","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2020.111105_bib0430","doi-asserted-by":"crossref","first-page":"28291","DOI":"10.1074\/jbc.M111.328674","article-title":"Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies","volume":"287","author":"Eberhardt","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111105_bib0435","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2019.02.019","article-title":"Methylglyoxal and a spinal TRPA1-AC1-Epac cascade facilitate pain in the db\/db mouse model of type 2 diabetes","volume":"127","author":"Griggs","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2020.111105_bib0440","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.7150\/thno.36077","article-title":"The role of Na(v)1.7 and methylglyoxal-mediated activation of TRPA1 in itch and hypoalgesia in a murine model of type 1 diabetes","volume":"9","author":"Cheng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2020.111105_bib0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ALN.0b013e3181a1642b","article-title":"Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals","volume":"111","author":"Wei","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopha.2020.111105_bib0450","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2011.10.006","article-title":"Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy","volume":"65","author":"Koivisto","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2020.111105_bib0455","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.sjpain.2012.11.001","article-title":"Transient receptor potential ankyrin 1 (TRPA1) ion channel in the pathophysiology of peripheral diabetic neuropathy","volume":"4","author":"Koivisto","year":"2013","journal-title":"Scand. J. Pain"},{"key":"10.1016\/j.biopha.2020.111105_bib0460","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/ppa.14.60","article-title":"Transient receptor potential ankyrin 1 (TRPA1) antagonists","volume":"4","author":"Preti","year":"2015","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.biopha.2020.111105_bib0465","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/0006-2952(91)90241-V","article-title":"Contribution of different amine oxidases to the metabolism of dopamine in bovine retina","volume":"42","author":"Fern\u00e1ndez de Arriba","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111105_bib0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cne.21784","article-title":"Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas","volume":"510","author":"Witkovsky","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2020.111105_bib0475","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2174\/092986708785133022","article-title":"Semicarbazide-sensitive amine oxidase\/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target","volume":"15","author":"Dunkel","year":"2008","journal-title":"Curr. Med. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:57:59Z","timestamp":1760097479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220312981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":95,"alternative-id":["S0753332220312981"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111105","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111105"}}